InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Cavanaugh Sarah, Directeur des Affaires Corporatives. Insider active across 1 companies, notably Celldex Therapeutics, Inc.. Aggregated, 4 filings have been published. The latest transaction was disclosed on 8 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€14,8481,857 shares@ €7.99580.0006% mcap27.5% of flow
Common Stock
SEC:0001179110-21-010820·
€14,8481,857 shares@ €7.99580.0006% mcap13.7% of flow
Common Stock
SEC:0001179110-21-010820:0·
€39,1505,018 shares@ €7.8020.0016% mcap72.5% of flow
Common Stock
SEC:0001179110-21-009818·
€39,1505,018 shares@ €7.8020.0016% mcap36.3% of flow
Common Stock
SEC:0001179110-21-009818:0·
4 of 4 declarations
About Cavanaugh Sarah
Sarah Cavanaugh is Senior Vice President of Corporate Affairs and Administration at Celldex Therapeutics, Inc. She oversees corporate affairs initiatives and ensures regulatory compliance. Her role is essential for the strategic development of the company.
